Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, TELADOC HEALTH, INC. reported revenue of $2.53B, down 1.5% year over year. Operating margin was -10.4% and net margin -7.9%, on a free-cash-flow margin of 11.3% with capital expenditure at 0.4% of revenue. Every figure is computed directly from TDOC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.53B | -10.4% | -7.9% |
| FY2024 | $2.57B | -39.7% | -39.0% |
| FY2023 | $2.60B | -9.6% | -8.5% |
| FY2022 | $2.41B | -567.3% | -567.5% |
| FY2021 | $2.03B | -13.1% | -21.1% |
How does TDOC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.